SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain

Rolek, B; Haber, M; Gajewska, M; Rogula, S; Pietrasik, A; Gasecka, A

Rogula, S (通讯作者),Med Univ Warsaw, Chair & Dept Cardiol 1, Ul Banacha 1A, PL-02097 Warsaw, Poland.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023; 10 (8):

Abstract

Sodium glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like-peptide-1 receptor (GLP-1-R) agonists are novel therapeutic agents used for the ma......

Full Text Link